Google DeepMind
This is the model-to-molecule workflow that biotech founders should be watching. If DeepMind can materially speed up antimicrobial discovery, the applications pipeline across pharma and biodefense just got shorter. The real test is whether candidates from this pipeline actually survive clinical testing.